Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003673 |
---|---|
Receipt number | R000004352 |
Scientific Title | FOLFOX plus bevacizumab alternated with sLV5FU2 plus bevacizumab as first-line chemotherapy for patients with metastatic colorectal cancer: a feasibility study |
Date of disclosure of the study information | 2010/05/31 |
Last modified on | 2015/05/10 16:34:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/29 20:20:50 | ||
2 | Update | 2010/05/29 20:22:55 | Interventions/Control_1 |
|
3 | Update | 2011/05/30 15:08:05 | Public title Acronym |
|
4 | Update | 2011/05/30 15:09:09 | Narrative objectives1 |
|
5 | Update | 2011/05/30 15:11:26 | Name of person sending information Organization Division name Address |
|
6 | Update | 2012/05/06 16:43:31 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2013/09/30 16:54:14 | TEL TEL |
|
8 | Update | 2015/05/10 16:34:16 | Recruitment status |